Offers a life-saving solution for end-stage heart failure patients who cannot receive a heart transplant or those waiting for a heart donor
Increases survival rates
Restores heart function, improving overall circulation and oxygen delivery
Increases survival rates
Restores heart function, improving overall circulation and oxygen delivery
Improves quality of life by reducing symptoms like fatigue, shortness of breath, and swelling, allowing patients to resume daily activities
Reduces the risk of organ damage caused by inadequate blood flow from a failing heart
Improves quality of life by reducing symptoms like fatigue, shortness of breath, and swelling, allowing patients to resume daily activities
Reduces the risk of organ damage caused by inadequate blood flow from a failing heart
A new multi-center study explores the Corheart 6, an implantable left ventricular assist system, and its impact on survival, heart function, and safety over six months. With zero device failures, significant improvements in heart performance, and a 92.3% survival rate, this study reveals promising results for a growing population with limited treatment options.
Request access now to view the full study and explore the data behind this breakthrough.





